Nanospectra Biosciences
Manufacturing · Texas, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
8285 El Rio St Ste 150, Houston, Texas, ...Phone Number
(713) 842-2720Website
www.nanospectra.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Nanospectra Biosciences
Nanospectra Biosciences is a medical device company focused on patient-centric nanomedicine for selective thermal ablation. Their proprietary AuroLase Therapy utilizes AuroShells, a new class of nanoparticles, to thermally destroy solid tumors while preserving healthy tissue. The company is advancing its technology through clinical trials and partnerships, aiming for multiple applications in oncology and drug delivery. Nanospectra's innovative approach seeks to enhance treatment efficacy and reduce side effects associated with traditional cancer therapies.Explore more
Nanospectra Biosciences Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Nanospectra Biosciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Nanospectra Biosciences recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Nanospectra Biosciences
Nanospectra Biosciences, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Nanospectra Biosciences has new funding data
Click to see if Nanospectra Biosciences had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Nanospectra Biosciences launches new products
Check if Nanospectra Biosciences has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Nanospectra Biosciences is spiking on competitors!
Recommended Actions
Find VP level buyers at Nanospectra Biosciences
Find 3 more new buyers
Compare Similar Companies to Nanospectra Biosciences
Compare insights from companies similar to Nanospectra Biosciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Nanospectra Biosciences
<$5M
1-10
Private
$10.6M
2002
JS
John SchwartzProject Manager, Clinical Research
Company Profile Activity
Activity Insights
Nanospectra Biosciences is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Nanospectra Biosciences is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Nanospectra Biosciences.
Nanospectra Biosciences financials insights
Gather financial insights about Nanospectra Biosciences, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2010
Unspecified
$872K
2013
Multiple Rounds
$2.9M
2014
Private Equity
$800K
2015
Private Equity
$945K
2017
Private Equity
$2M
2020
Other Financing Round
$3M
Nanospectra Biosciences Tech Stack
A closer look at the technologies used by Nanospectra Biosciences
See more technologies
Nanospectra Biosciences News & Media
Nanospectra Bio nets Sirtex backing for gold nanoparticle prostate cancer therapy
Sirtex Medical, maker of a radioactive microsphere implant for treating liver tumors, has made a strategic investment in the developer of a prostate cancer therapy featuring laser-charged gold particles, Nanospectra Biosciences.Nanospectra Biosciences Raises First Tranche of Series B-1 Funding Led by Sirtex Medical
HOUSTON, Sept. 8, 2020 /PRNewswire/ -- Nanospectra Biosciences, Inc., a medical device company pioneering a novel use of nanomedicine for selective thermal ablation, today announced that it has closed on an initial $3 million in a Series B-1 financing with total approved capital of up to...Nanospectra Biosciences Announces Four Additional Prestigious Trial Sites for Pivotal AuroLase Study
HOUSTON, Aug. 4, 2020 /PRNewswire/ -- Nanospectra Biosciences, Inc., a medical device company pioneering a novel use of nanomedicine for selective thermal ablation, today announced the addition of four clinical trial sites to its ongoing AuroLase® pivotal study. The extension study is...Nanospectra Biosciences Initiates Pivotal Study of AuroLase Therapy for Ablation of Prostate Tissue
HOUSTON, Feb. 4, 2020 /PRNewswire/ -- Nanospectra Biosciences, Inc., a medical device company pioneering a novel use of nanomedicine for selective thermal ablation, today announced the start of a pivotal study to determine the efficacy of using MRI/US fusion imaging technology to direct...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Nanospectra Biosciences
Sign Up For FreeTo access detailed company insights
Nanospectra Biosciences is a medical device company focused on patient-centric nanomedicine for selective thermal ablation. Their proprietary AuroLase Therapy utilizes AuroShells, a new class of nanoparticles, to thermally destroy solid tumors while preserving healthy tissue. The company is advancing its technology through clinical trials and partn... Read More
